Qube Research & Technologies (QRT)
ROIV icon

Qube Research & Technologies (QRT)’s Roivant Sciences ROIV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122M Buy
3,454,496
+3,592
+0.1% +$106K 0.11% 225
2026
Q1 		$95.6M Buy
3,450,904
+2,691,685
+355% +$69.1M 0.11% 227
2025
Q4 		$16.5M Buy
+759,219
New +$15M 0.02% 1022
2024
Q2 		– Sell
-85,952
Closed -$906K – 4575
2024
Q1 		$906K Buy
+85,952
New +$927K ﹤0.01% 2199

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ROIV Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Roivant Sciences (ROIV) stake by 0.1% in Q2 2026, buying an estimated $106K and bringing the position to 3,454,496 shares worth $122M. The position accounts for 0.11% of the portfolio, ranked #225.

Qube Research & Technologies (QRT) first reported a position in ROIV in Q1 2024 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Qube Research & Technologies (QRT) held 3,454,496 shares of Roivant Sciences worth $122M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 3,592 Roivant Sciences shares in Q2 2026, an estimated $106K.
  • Roivant Sciences made up 0.11% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #225 holding.
  • Qube Research & Technologies (QRT) first reported a position in Roivant Sciences in Q1 2024 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.